These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7762497)

  • 1. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
    Boden WE
    Drugs; 1996; 52 Suppl 4():20-30. PubMed ID: 8913715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.
    Théroux P; Grégoire J; Chin C; Pelletier G; de Guise P; Juneau M
    J Am Coll Cardiol; 1998 Sep; 32(3):620-8. PubMed ID: 9741502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine versus aspirin after myocardial infarction (STAMI) trial.
    Scrutinio D; Cimminiello C; Marubini E; Pitzalis MV; Di Biase M; Rizzon P
    J Am Coll Cardiol; 2001 Apr; 37(5):1259-65. PubMed ID: 11300432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rescue thrombolysis in patients with acute myocardial infarction: preliminary findings.
    Sarullo FM; Americo L; Di Pasquale P; Castello A; Mauri F
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):83-9. PubMed ID: 10755205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.
    Gibson CM; Mega JL; Burton P; Goto S; Verheugt F; Bode C; Plotnikov A; Sun X; Cook-Bruns N; Braunwald E
    Am Heart J; 2011 May; 161(5):815-821.e6. PubMed ID: 21570509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
    Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography.
    Gibson RS
    Drugs; 1991; 42 Suppl 2():28-37. PubMed ID: 1718699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
    Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blockers as adjuvant therapy postthrombolysis.
    Boden WE
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S102-6. PubMed ID: 1724997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.